Minnesota Legislature
Audio/Video Archives - 2023-2024 Regular Session
Health Finance and Policy
Meetings are listed by date with the most recent meeting at the top. If there is a television recording of the meeting links to that format will be available below.
Health Finance and Policy
2/7/2023
HF51 (Richardson) - Emmett Louis Till Victims Recovery Program established, and money appropriated.
HF1059 (Richardson) - Grants supporting healthy development of babies during pregnancy and postpartum for families with members who are Black, Indigenous, and People of Color funding provided, and money appropriated.
HF639 (Bahner) - Community solutions for healthy child development grant program established, and money appropriated.
HF712 (Reyer) - Family planning grant funding provided, and money appropriated.
HF1030 (Liebling) - Enrollee cost-sharing eliminated under medical assistance and MinnesotaCare; and individual, small group, and State Employee Group Insurance Program plans prohibited from including cost-sharing.
PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows, and written testimony is encouraged.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
HF1059 (Richardson) - Grants supporting healthy development of babies during pregnancy and postpartum for families with members who are Black, Indigenous, and People of Color funding provided, and money appropriated.
HF639 (Bahner) - Community solutions for healthy child development grant program established, and money appropriated.
HF712 (Reyer) - Family planning grant funding provided, and money appropriated.
HF1030 (Liebling) - Enrollee cost-sharing eliminated under medical assistance and MinnesotaCare; and individual, small group, and State Employee Group Insurance Program plans prohibited from including cost-sharing.
PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows, and written testimony is encouraged.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
HF51
(Richardson) - Emmett Louis Till Victims Recovery Program established, and money appropriated.
HF1059 (Richardson) - Grants supporting healthy development of babies during pregnancy and postpartum for families with members who are Black, Indigenous, and People of Color funding provided, and money appropriated.
HF639 (Bahner) - Community solutions for healthy child development grant program established, and money appropriated.
HF712 (Reyer) - Family planning grant funding provided, and money appropriated.
HF1030 (Liebling) - Enrollee cost-sharing eliminated under medical assistance and MinnesotaCare; and individual, small group, and State Employee Group Insurance Program plans prohibited from including cost-sharing.
Attachments:
HF1059 (Richardson) - Grants supporting healthy development of babies during pregnancy and postpartum for families with members who are Black, Indigenous, and People of Color funding provided, and money appropriated.
HF639 (Bahner) - Community solutions for healthy child development grant program established, and money appropriated.
HF712 (Reyer) - Family planning grant funding provided, and money appropriated.
HF1030 (Liebling) - Enrollee cost-sharing eliminated under medical assistance and MinnesotaCare; and individual, small group, and State Employee Group Insurance Program plans prohibited from including cost-sharing.
HF1059 HRS.pdf
(2/6/2023)
HF639 HRS.pdf (2/6/2023)
HF712 HRS.pdf (2/6/2023)
HF1030 HRS.pdf (2/6/2023)
2023 Community Solutions One Pager (1).pdf (2/6/2023)
2023 RHA One Pager on Family Planning Grants 2.4.23.pdf (2/6/2023)
2023 VC Legislative Agenda Final.pdf (2/6/2023)
2023.02.03 NFIB MN Ltr re HF 1030 (Eliminate Cost Sharing).pdf (2/6/2023)
CommSolnGrantProg.PeopleServingPeople.LOS.2.7.23.pdf (2/6/2023)
Ada's Story.pdf (2/6/2023)
HF1030 MCHP Letter House Health_2023.02.06.docx (2/6/2023)
Letter of Support (HF639).docx (2/6/2023)
MDH One Pager on Family Planning Grants 2.4.23.pdf (2/6/2023)
myHealth Letter of Support HF712 FPSP .pdf (2/6/2023)
PN3 Support HF639_CSF_Health Finance & Policy_02.06.23.pdf (2/6/2023)
Support Letter For HF 639.docx (2/6/2023)
HF639 letter of support.docx (2/6/2023)
Annex Teen Clinic Testimony in Support of HF 712.pdf (2/6/2023)
Eliminate Cost-Sharing -TAMN SEIU.pdf (2/6/2023)
Letter of Support HF 390 Feb 2023.docx (2/6/2023)
H0051A2-1-2833566875097505225.pdf (2/6/2023)
Health Finance & Policy Agenda 02.07.23.docx (2/6/2023)
Gender Justice - HF 1059 Letter of Support-2.pdf (2/6/2023)
WFM HF712 Family Planning Grant [82].pdf (2/6/2023)
HFP Minutes 9th 2-2-2023.docx (2/6/2023)
0051a2-1 Richardson.ek.pdf (2/7/2023)
HF 639 Letter of Support.pdf (2/7/2023)
Losloso Letter of Support HF639.pdf (2/7/2023)
PN3_Support HF 1059_AABC_Health F&P_02.07.23.pdf (2/7/2023)
HF639 HRS.pdf (2/6/2023)
HF712 HRS.pdf (2/6/2023)
HF1030 HRS.pdf (2/6/2023)
2023 Community Solutions One Pager (1).pdf (2/6/2023)
2023 RHA One Pager on Family Planning Grants 2.4.23.pdf (2/6/2023)
2023 VC Legislative Agenda Final.pdf (2/6/2023)
2023.02.03 NFIB MN Ltr re HF 1030 (Eliminate Cost Sharing).pdf (2/6/2023)
CommSolnGrantProg.PeopleServingPeople.LOS.2.7.23.pdf (2/6/2023)
Ada's Story.pdf (2/6/2023)
HF1030 MCHP Letter House Health_2023.02.06.docx (2/6/2023)
Letter of Support (HF639).docx (2/6/2023)
MDH One Pager on Family Planning Grants 2.4.23.pdf (2/6/2023)
myHealth Letter of Support HF712 FPSP .pdf (2/6/2023)
PN3 Support HF639_CSF_Health Finance & Policy_02.06.23.pdf (2/6/2023)
Support Letter For HF 639.docx (2/6/2023)
HF639 letter of support.docx (2/6/2023)
Annex Teen Clinic Testimony in Support of HF 712.pdf (2/6/2023)
Eliminate Cost-Sharing -TAMN SEIU.pdf (2/6/2023)
Letter of Support HF 390 Feb 2023.docx (2/6/2023)
H0051A2-1-2833566875097505225.pdf (2/6/2023)
Health Finance & Policy Agenda 02.07.23.docx (2/6/2023)
Gender Justice - HF 1059 Letter of Support-2.pdf (2/6/2023)
WFM HF712 Family Planning Grant [82].pdf (2/6/2023)
HFP Minutes 9th 2-2-2023.docx (2/6/2023)
0051a2-1 Richardson.ek.pdf (2/7/2023)
HF 639 Letter of Support.pdf (2/7/2023)
Losloso Letter of Support HF639.pdf (2/7/2023)
PN3_Support HF 1059_AABC_Health F&P_02.07.23.pdf (2/7/2023)
Health Finance and Policy
2/2/2023
Lead overview from MDH Assistant Commissioner Dan Huff.
HF92 (Jordan) - Elevated blood lead concentration level lowered from ten micrograms of lead to 3.5 micrograms.
HF24 (Jordan) - Authority modified to ensure safe drinking water, drinking water revolving fund provisions modified, grant program established to replace lead drinking water service lines, grant program established for mapping lead service lines, report required, and money appropriated.
HF347 (Howard) - Lead testing and remediation requirements in schools modified, report required, and money appropriated.
HFXXXX (Jordan) - State definition of lead service line, non-lead service line, galvanized service line, and galvanized service line in need of replacement.
HFXXXX (Jordan) - Modifying renovation and lead hazard reduction provisions.
Bills may be added or removed at the discretion of the chair.
PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows, and written testimony is encouraged.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
HF92 (Jordan) - Elevated blood lead concentration level lowered from ten micrograms of lead to 3.5 micrograms.
HF24 (Jordan) - Authority modified to ensure safe drinking water, drinking water revolving fund provisions modified, grant program established to replace lead drinking water service lines, grant program established for mapping lead service lines, report required, and money appropriated.
HF347 (Howard) - Lead testing and remediation requirements in schools modified, report required, and money appropriated.
HFXXXX (Jordan) - State definition of lead service line, non-lead service line, galvanized service line, and galvanized service line in need of replacement.
HFXXXX (Jordan) - Modifying renovation and lead hazard reduction provisions.
Bills may be added or removed at the discretion of the chair.
PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows, and written testimony is encouraged.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
HF24
(Jordan) - Lead drinking water service line replacement grant program established, report required, and money appropriated.
HF92 (Jordan) - Elevated blood lead concentration level lowered from ten micrograms of lead to 3.5 micrograms.
HF347 (Howard) - Lead testing and remediation requirements in schools modified, report required, and money appropriated.
Attachments:
HF92 (Jordan) - Elevated blood lead concentration level lowered from ten micrograms of lead to 3.5 micrograms.
HF347 (Howard) - Lead testing and remediation requirements in schools modified, report required, and money appropriated.
2203 23-00388 (Jordan).pdf
(1/30/2023)
2205 23-00389 (Jordan).pdf (1/30/2023)
HF92 HRS.pdf (2/1/2023)
HF24 HRS.pdf (2/1/2023)
HF347 HRS.pdf (2/1/2023)
HFP Minutes 8th 1-31-2023.docx (2/1/2023)
ConservationMinnesotaSupportsHF24.pdf (2/1/2023)
HF24 TNC Support Letter.pdf (2/1/2023)
Housing First Comments RRP Rule.pdf (2/1/2023)
Lead Pipes Handout 1.17.23.pdf (2/1/2023)
20230202 MDH Lead Overview - House Health.pdf (2/1/2023)
HF 24 Letter of Support.pdf (2/1/2023)
Health Finance & Policy Agenda 02.02.23.docx (2/1/2023)
H0347A3-3796622639077288512.pdf (2/2/2023)
2205 23-00389 (Jordan).pdf (1/30/2023)
HF92 HRS.pdf (2/1/2023)
HF24 HRS.pdf (2/1/2023)
HF347 HRS.pdf (2/1/2023)
HFP Minutes 8th 1-31-2023.docx (2/1/2023)
ConservationMinnesotaSupportsHF24.pdf (2/1/2023)
HF24 TNC Support Letter.pdf (2/1/2023)
Housing First Comments RRP Rule.pdf (2/1/2023)
Lead Pipes Handout 1.17.23.pdf (2/1/2023)
20230202 MDH Lead Overview - House Health.pdf (2/1/2023)
HF 24 Letter of Support.pdf (2/1/2023)
Health Finance & Policy Agenda 02.02.23.docx (2/1/2023)
H0347A3-3796622639077288512.pdf (2/2/2023)
Health Finance and Policy
1/31/2023
HF293 (Elkins): Medical and dental practices required to make available to the public their current standard charges, and commissioner of health authorized to establish a price comparison tool for items and services offered by medical and dental practices.
HF294 (Elkins): Manufacturers required to report and maintain prescription drug prices, filing of health plan prescription drug formularies required, health care coverage provisions modified, prescription benefit tool requirements established, and prescription drug benefit transparency and disclosure required.
HF926 (Elkins): Payments made to health care providers disclosure required, all-payer claims data provision changed, and transparency of health care payments report required.
Bills may be added or removed at the discretion of the chair.
AMENDMENTS: Deadline for amendments is 5:00PM, Monday, January 30, 2023.
PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows, and written testimony is encouraged.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
HF294 (Elkins): Manufacturers required to report and maintain prescription drug prices, filing of health plan prescription drug formularies required, health care coverage provisions modified, prescription benefit tool requirements established, and prescription drug benefit transparency and disclosure required.
HF926 (Elkins): Payments made to health care providers disclosure required, all-payer claims data provision changed, and transparency of health care payments report required.
Bills may be added or removed at the discretion of the chair.
AMENDMENTS: Deadline for amendments is 5:00PM, Monday, January 30, 2023.
PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows, and written testimony is encouraged.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
HF293
(Elkins) - Medical and dental practices required to make available to the public their current standard charges, and commissioner of health authorized to establish a price comparison tool for items and services offered by medical and dental practices.
HF294 (Elkins) - Manufacturers required to report and maintain prescription drug prices, filing of health plan prescription drug formularies required, health care coverage provisions modified, prescription benefit tool requirements established, and prescription drug benefit transparency and disclosure required.
HF926 (Elkins) - Payments made to health care providers disclosure required, self-insurer governing provision added, all-payer claims data provision changed, and transparency of health care payments report required.
Attachments:
HF294 (Elkins) - Manufacturers required to report and maintain prescription drug prices, filing of health plan prescription drug formularies required, health care coverage provisions modified, prescription benefit tool requirements established, and prescription drug benefit transparency and disclosure required.
HF926 (Elkins) - Payments made to health care providers disclosure required, self-insurer governing provision added, all-payer claims data provision changed, and transparency of health care payments report required.
H0294A2-1162106730250537746.pdf
(1/27/2023)
H0926A1-12634486762228670843.pdf (1/30/2023)
AAM Letter - HF294 .pdf (1/30/2023)
Abraham_MNHouse_HF293_1302023.pdf (1/30/2023)
AHIP Comments on MN HF 294.pdf (1/30/2023)
CAE Comments on HF293 HF 294 and HF 926.pdf (1/30/2023)
EFMN Comments on HF 294.pdf (1/30/2023)
HF 294 __ Prescription Drug Benefit Transparency and Disclosure Required _ Frozen Formulary _ PCMA Testimony __ Michelle Mack __ House Health and Finance Policy _ FINAL.pdf (1/30/2023)
MAFP_Support HF 926.pdf (1/30/2023)
HF293 HRS.pdf (1/30/2023)
HF926 HRS.pdf (1/30/2023)
H0294A1-13846754184717982985.pdf (1/31/2023)
Health Finance & Policy Agenda 01.31.23.docx (1/31/2023)
TakingThePulse.pdf (1/31/2023)
PhRMA Statement - MN HF 294 Transparency & Price Control.pdf (1/31/2023)
Vertical-Integration-DCI-Oct2022.pdf (1/31/2023)
Supply Chain Slide.pdf (1/31/2023)
PPL_Updated Overview One-Pager[1].pdf (1/31/2023)
PBM-market-share-DCI-2021.pdf (1/31/2023)
More Than Half of Every Dollar Spent on Medicines Goes to Someone Who Doesnt Make Them 4ALT.pdf (1/31/2023)
Why Hospitals and Health Insurers Didn’t Want You to See Their Prices - The New York Times.pdf (1/31/2023)
What Does Knee Surgery Cost_ Few Know, and That’s a Problem - WSJ.pdf (1/31/2023)
Schafer_ We already knew hospital pricing was a mess, so now what_.pdf (1/31/2023)
Hospitals Hide Pricing Data From Search Results - WSJ.pdf (1/31/2023)
9-15-21-Hospital_Price_Transparency.pdf (1/31/2023)
HF58-2E (HF294) Evaluation Report.pdf (1/31/2023)
Milliman_Frozen Formulary Report_FINAL.pdf (1/31/2023)
HF294 HRS.pdf (1/31/2023)
HF 293 Elkins MNASCA MNOncology MSIPP.pdf (1/31/2023)
H0926A1-12634486762228670843.pdf (1/30/2023)
AAM Letter - HF294 .pdf (1/30/2023)
Abraham_MNHouse_HF293_1302023.pdf (1/30/2023)
AHIP Comments on MN HF 294.pdf (1/30/2023)
CAE Comments on HF293 HF 294 and HF 926.pdf (1/30/2023)
EFMN Comments on HF 294.pdf (1/30/2023)
HF 294 __ Prescription Drug Benefit Transparency and Disclosure Required _ Frozen Formulary _ PCMA Testimony __ Michelle Mack __ House Health and Finance Policy _ FINAL.pdf (1/30/2023)
MAFP_Support HF 926.pdf (1/30/2023)
HF293 HRS.pdf (1/30/2023)
HF926 HRS.pdf (1/30/2023)
H0294A1-13846754184717982985.pdf (1/31/2023)
Health Finance & Policy Agenda 01.31.23.docx (1/31/2023)
TakingThePulse.pdf (1/31/2023)
PhRMA Statement - MN HF 294 Transparency & Price Control.pdf (1/31/2023)
Vertical-Integration-DCI-Oct2022.pdf (1/31/2023)
Supply Chain Slide.pdf (1/31/2023)
PPL_Updated Overview One-Pager[1].pdf (1/31/2023)
PBM-market-share-DCI-2021.pdf (1/31/2023)
More Than Half of Every Dollar Spent on Medicines Goes to Someone Who Doesnt Make Them 4ALT.pdf (1/31/2023)
Why Hospitals and Health Insurers Didn’t Want You to See Their Prices - The New York Times.pdf (1/31/2023)
What Does Knee Surgery Cost_ Few Know, and That’s a Problem - WSJ.pdf (1/31/2023)
Schafer_ We already knew hospital pricing was a mess, so now what_.pdf (1/31/2023)
Hospitals Hide Pricing Data From Search Results - WSJ.pdf (1/31/2023)
9-15-21-Hospital_Price_Transparency.pdf (1/31/2023)
HF58-2E (HF294) Evaluation Report.pdf (1/31/2023)
Milliman_Frozen Formulary Report_FINAL.pdf (1/31/2023)
HF294 HRS.pdf (1/31/2023)
HF 293 Elkins MNASCA MNOncology MSIPP.pdf (1/31/2023)
Health Finance and Policy
1/30/2023
Audio Available: Download Mp3
Joint hearing of the Commerce Finance & Policy and Health Finance & Policy Committees.
Testimony from stakeholders on proposed Fairview/Sanford merger (groups may be added; no public testimony)
Fairview Health Services
Sanford Health
Office of the Attorney General
University of Minnesota
Minnesota Nurses Association
HFXXXX (Bierman); prohibiting health care entities from entering into certain transactions except with the review and approval of the commissioner of health
Informational hearing, no action will be taken
Items may be added, removed, or taken up in any order at the Chair’s discretion
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
Testimony from stakeholders on proposed Fairview/Sanford merger (groups may be added; no public testimony)
Fairview Health Services
Sanford Health
Office of the Attorney General
University of Minnesota
Minnesota Nurses Association
HFXXXX (Bierman); prohibiting health care entities from entering into certain transactions except with the review and approval of the commissioner of health
Informational hearing, no action will be taken
Items may be added, removed, or taken up in any order at the Chair’s discretion
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
Bierman Draft.pdf
(1/27/2023)
Health Finance and Policy
1/26/2023
HF 366 (Agbaje): Reproductive health care; health records release limited, certain acts by health-related licensing boards prohibited etc.
Committee will hear testimony relating only to those parts of the bill under our jurisdiction: Sections 1-4, Health Records and Health Licensing Boards.
Other bills may be added.
PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows, and written testimony is encouraged.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
Committee will hear testimony relating only to those parts of the bill under our jurisdiction: Sections 1-4, Health Records and Health Licensing Boards.
Other bills may be added.
PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows, and written testimony is encouraged.
To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
HF366
(Agbaje) - Reproductive health care; health records release limited, health-related licensing board acts prohibited, background study disqualification prohibited, judgement enforcement prevented, subpoena enforcement restricted, lawsuit cause of action created, and extradition of persons charged in another state prohibited.
Attachments:
H0366A1-2423500793330141262.pdf
(1/25/2023)
Gender Justice - HF 366 Letter of Support.pdf (1/25/2023)
HF366 HRS.pdf (1/25/2023)
Health Finance & Policy Agenda 01.26.23.docx (1/25/2023)
Kromenaker Testimony in Support of Reproductive Freedom Defense Act 1.25.2023.pdf (1/26/2023)
Gender Justice - HF 366 Letter of Support.pdf (1/25/2023)
HF366 HRS.pdf (1/25/2023)
Health Finance & Policy Agenda 01.26.23.docx (1/25/2023)
Kromenaker Testimony in Support of Reproductive Freedom Defense Act 1.25.2023.pdf (1/26/2023)
Select Criteria
Choose a session year below - all committee audio recordings for that year will be listed in the results column.
Choose a committee below - this list is based on the chosen session year and will filter results to that specific committee.
Minnesota House of Representatives · 100 Rev. Dr. Martin Luther King Jr. Blvd. Saint Paul, MN 55155 · Webmaster@house.mn